Abstract
Frequent tests for CD4+ T cell counting are important for the treatment of patients with immune deficiency; however, the routinely used fluorescence-activated cell-sorting (FACS) gold standard is costly and the equipment is only available in central hospitals. In this study, we developed an alternative simple approach (shortly named as the MACS-Countess system) for CD4+ T cell counting by coupling magnetic activated cell sorting (MACS) to separate CD4+ T cells from blood, followed by counting the separated cells using CountessTM, an automated cell-counting system. Using the cell counting protocol, 25 µL anti-CD4 conjugated magnetic nanoparticles (NP-CD4, BD Bioscience) were optimized for separating CD4+ T cells from 50 µL of blood in PBS using a DynamagTM-2 magnet, followed by the introduction of 10 µL separated cells into a CountessTM chamber slide for automated counting of CD4+ T cells. To evaluate the reliability of the developed method, 48 blood samples with CD4+ T cell concentrations ranging from 105 to 980 cells/µL were analyzed using both MACS-Countess and FACS. Compared with FACS, MACS-Countess had a mean bias of 3.5% with a limit of agreement (LoA) ranging from −36.4% to 43.3%, which is close to the reliability of the commercial product, PIMA analyzer (Alere), reported previously (mean bias 0.2%; LoA ranging from −42% to 42%, FACS as reference). Further, the MACS-Countess system requires very simple instruments, including only a magnet and an automated cell counter, which are affordable for almost every lab located in a limited resource region.
Highlights
To support the treatment of HIV/AIDS and other deficient immune diseases, CD4+Tcell counts are frequently monitored using highly reliable equipment
In an attempt to reduce the gap between magnetic activated cell sorting (MACS) utilization and CD4+ T cell counting applications, we developed a CD4+ T cell counting system based on a simple MACSseparation for CD4+ T cells using a small blood input required, followed by automated cell counting
peripheral blood mononuclear cells (PBMCs) is known to be rich in CD4+ T cells (35%, [28]); to test the performance of NP-CD4 for the targeted cells, we first performed CD4+ T cell separation from PBMCs according to the recommended protocol
Summary
To support the treatment of HIV/AIDS and other deficient immune diseases, CD4+Tcell counts are frequently monitored using highly reliable equipment. CD4+ T cell concentrations reflect the immune status of patients; in HIV-infected individuals, CD4+ T cell counts are usually lower than 500 cells/μL of blood and patients who progress to AIDS have fewer than 200 cells/μL [2]. The key mechanism of cell sorting by FACS is that fluorescence-labeled antibodies recognize and bind to markers expressed on cells; the cells are passed through single-cell flow and fluorescence signals are detected using a laser beam. To confirm whether the separated cells are CD4+ T cells, a mixture of distinctive fluorescent dyes conjugated with CD4 and CD3 monoclonal antibodies is usually used for targeting the corresponding markers on CD4+ T cells, which do not co-appear on other cells expressing CD4 alone
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have